Pfizer Total Long-Term Assets 2010-2025 | PFE

Pfizer total long-term assets for the quarter ending March 31, 2025 were $162.167B, a 9.24% decline year-over-year.

  • Pfizer total long-term assets for 2024 were $163.037B, a 10.99% decline from 2023.
  • Pfizer total long-term assets for 2023 were $183.168B, a 25.51% increase from 2022.
  • Pfizer total long-term assets for 2022 were $145.944B, a 19.84% increase from 2021.

Pfizer Total Long-Term Assets 2010-2025 | PFE

  • Pfizer total long-term assets for 2024 were $163.037B, a 10.99% decline from 2023.
  • Pfizer total long-term assets for 2023 were $183.168B, a 25.51% increase from 2022.
  • Pfizer total long-term assets for 2022 were $145.944B, a 19.84% increase from 2021.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$731.4B
Johnson & Johnson (JNJ)$393.9B
AbbVie (ABBV)$334.3B
Novo Nordisk (NVO)$287.1B
Roche Holding AG (RHHBY)$255.6B
Novartis AG (NVS)$241.3B
Merck (MRK)$200.8B
Sanofi (SNY)$118.5B
Bayer (BAYRY)$31.2B
Innoviva (INVA)$1.2B